Cargando…
Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
BACKGROUND: Osteosarcoma initially metastasing to bone only shows distinct biological features compared to osteosarcoma that firstly metastasizes to the lung, which suggests us underlying different genomic pathogenetic mechanism. METHODS: We analyzed whole-exome sequencing (WES) data for 38 osteosar...
Autores principales: | Xie, Lu, Cai, Zhenyu, Lu, Hezhe, Meng, Fanfei, Zhang, Xin, Luo, Kun, Su, Xiaoxing, Lei, Yan, Xu, Jiuhui, Lou, Jingbing, Wang, Han, Du, Zhiye, Wang, Yunfan, Li, Yuan, Ren, Tingting, Xu, Jie, Sun, Xin, Tang, Xiaodong, Guo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189180/ https://www.ncbi.nlm.nih.gov/pubmed/37205995 http://dx.doi.org/10.1016/j.heliyon.2023.e15527 |
Ejemplares similares
-
circUSP34 accelerates osteosarcoma malignant progression by sponging miR‐16‐5p
por: Lou, Jingbing, et al.
Publicado: (2021) -
Immune-Related LncRNAs Affect the Prognosis of Osteosarcoma, Which Are Related to the Tumor Immune Microenvironment
por: Huang, Qingshan, et al.
Publicado: (2021) -
Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma
por: Huang, Qingshan, et al.
Publicado: (2021) -
The malignancy of chordomas is enhanced via a circTLK1/miR-16-5p/Smad3 positive feedback axis
por: Lou, Jingbing, et al.
Publicado: (2023) -
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)